New Study Reinforces Major Advantages Of Dako North America, Inc. (Acquired by Agilent Technologies, Inc.)'s Her2 Iqfish Pharmdx™ In Breast Cancer Diagnostics

GLOSTRUP, Denmark, Feb. 14, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, today announced positive findings in an independent French multicenter study on the performance of Dako's HER2 IQFISH pharmDx(TM).

Help employers find you! Check out all the jobs and post your resume.